Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 251

1.

Late Steroid Withdrawal Following AB0-Incompatible Renal Transplantation.

Bachmann F, Lachmann N, Budde K, Liefeldt L, Halleck F, Naik M, Friedersdorff F, Rudolph B, Wu K, Meyer O, Slowinski T, Waiser J.

Transplant Proc. 2018 Jan - Feb;50(1):72-78. doi: 10.1016/j.transproceed.2017.12.008.

PMID:
29407335
2.

High Incidence of Ovarian Cysts in Women Receiving mTOR Inhibitors After Renal Transplantation.

Bachmann F, Glander P, Budde K, Bachmann C.

J Womens Health (Larchmt). 2018 Mar;27(3):394-398. doi: 10.1089/jwh.2017.6451. Epub 2017 Oct 31.

PMID:
29087803
3.

The novel microtubule targeting agent BAL101553 in combination with radiotherapy in treatment-refractory tumor models.

Sharma A, Broggini-Tenzer A, Vuong V, Messikommer A, Nytko KJ, Guckenberger M, Bachmann F, Lane HA, Pruschy M.

Radiother Oncol. 2017 Sep;124(3):433-438. doi: 10.1016/j.radonc.2017.07.024. Epub 2017 Aug 7.

PMID:
28797699
4.

Potential Antiosteoporotic Natural Product Lead Compounds That Inhibit 17β-Hydroxysteroid Dehydrogenase Type 2.

Vuorinen A, Engeli RT, Leugger S, Bachmann F, Akram M, Atanasov AG, Waltenberger B, Temml V, Stuppner H, Krenn L, Ateba SB, Njamen D, Davis RA, Odermatt A, Schuster D.

J Nat Prod. 2017 Apr 28;80(4):965-974. doi: 10.1021/acs.jnatprod.6b00950. Epub 2017 Mar 20.

5.

Treatment of Acute Antibody-Mediated Renal Allograft Rejection With Cyclophosphamide.

Waiser J, Duerr M, Budde K, Rudolph B, Wu K, Bachmann F, Halleck F, Schönemann C, Lachmann N.

Transplantation. 2017 Oct;101(10):2545-2552. doi: 10.1097/TP.0000000000001617.

PMID:
28009783
6.

Active sites in heterogeneous ice nucleation-the example of K-rich feldspars.

Kiselev A, Bachmann F, Pedevilla P, Cox SJ, Michaelides A, Gerthsen D, Leisner T.

Science. 2017 Jan 27;355(6323):367-371. doi: 10.1126/science.aai8034. Epub 2016 Dec 8.

PMID:
27940582
7.

Risk Evaluation and Outcome of Pneumocystis jirovecii Pneumonia in Kidney Transplant Patients.

Brakemeier S, Dürr M, Bachmann F, Schmidt D, Gaedeke J, Budde K.

Transplant Proc. 2016 Nov;48(9):2924-2930. doi: 10.1016/j.transproceed.2016.05.017.

PMID:
27932109
8.

The Novel Tubulin-Binding Checkpoint Activator BAL101553 Inhibits EB1-Dependent Migration and Invasion and Promotes Differentiation of Glioblastoma Stem-like Cells.

Bergès R, Tchoghandjian A, Honoré S, Estève MA, Figarella-Branger D, Bachmann F, Lane HA, Braguer D.

Mol Cancer Ther. 2016 Nov;15(11):2740-2749. Epub 2016 Aug 18.

9.

Experience with belatacept rescue therapy in kidney transplant recipients.

Brakemeier S, Kannenkeril D, Dürr M, Braun T, Bachmann F, Schmidt D, Wiesener M, Budde K.

Transpl Int. 2016 Nov;29(11):1184-1195. doi: 10.1111/tri.12822. Epub 2016 Sep 14.

10.

Successful Recovery of Acute Renal Transplant Failure in Recurrent Hepatitis C Virus-Associated Membranoproliferative Glomerulonephritis.

Schrezenmeier E, Wu K, Halleck F, Liefeldt L, Brakemeier S, Bachmann F, Kron S, Budde K, Duerr M.

Am J Transplant. 2017 Mar;17(3):819-823. doi: 10.1111/ajt.14091. Epub 2016 Nov 22.

11.

[Sporadic Lymphangioleiomyomatosis (sLAM) and Tuberous Sclerosis Complex (TSC) - Pulmonary Manifestations].

Brakemeier S, Grohé C, Bachmann F, Budde K.

Pneumologie. 2017 Feb;71(2):e1. doi: 10.1055/s-0036-1584699. Epub 2016 Sep 29. German. No abstract available.

PMID:
27685095
12.

Treatment of renal angiomyolipoma in tuberous sclerosis complex (TSC) patients.

Brakemeier S, Bachmann F, Budde K.

Pediatr Nephrol. 2017 Jul;32(7):1137-1144. doi: 10.1007/s00467-016-3474-6. Epub 2016 Sep 1. Review.

PMID:
27585680
13.

[Sporadic Lymphangioleiomyomatosis (sLAM) and Tuberous Sclerosis Complex (TSC) - Pulmonary Manifestations].

Brakemeier S, Grohé C, Bachmann F, Budde K.

Pneumologie. 2017 Feb;71(2):86-95. doi: 10.1055/s-0042-111522. Epub 2016 Sep 1. Review. German. Erratum in: Pneumologie. 2017 Feb;71(2):e1.

PMID:
27585353
14.

Clinical outcome of norovirus infection in renal transplant patients.

Brakemeier S, Taxeidi SI, Dürr M, Hofmann J, Schmidt D, Bachmann F, Gaedeke J, Budde K.

Clin Transplant. 2016 Oct;30(10):1283-1293. doi: 10.1111/ctr.12820. Epub 2016 Aug 23.

PMID:
27447127
15.

Autoantibodies against thrombospondin type 1 domain-containing 7A induce membranous nephropathy.

Tomas NM, Hoxha E, Reinicke AT, Fester L, Helmchen U, Gerth J, Bachmann F, Budde K, Koch-Nolte F, Zahner G, Rune G, Lambeau G, Meyer-Schwesinger C, Stahl RA.

J Clin Invest. 2016 Jul 1;126(7):2519-32. doi: 10.1172/JCI85265. Epub 2016 May 23.

16.

Oral anticoagulants in coronary heart disease (Section IV). Position paper of the ESC Working Group on Thrombosis - Task Force on Anticoagulants in Heart Disease.

De Caterina R, Husted S, Wallentin L, Andreotti F, Arnesen H, Bachmann F, Baigent C, Collet JP, Halvorsen S, Huber K, Jespersen J, Kristensen SD, Lip GY, Morais J, Rasmussen LH, Ricci F, Sibbing D, Siegbahn A, Storey RF, Ten Berg J, Verheugt FW, Weitz JI.

Thromb Haemost. 2016 Apr;115(4):685-711. doi: 10.1160/TH15-09-0703. Epub 2016 Mar 8. Review.

PMID:
26952877
17.

The impact of adverse reactions to injectable filler substances on quality of life: results from the Berlin Injectable Filler Safety (IFS) - study.

Düker D, Erdmann R, Hartmann V, Nast A, Rzany B, Bachmann F.

J Eur Acad Dermatol Venereol. 2016 Jun;30(6):1013-20. doi: 10.1111/jdv.13594. Epub 2016 Feb 25.

PMID:
26916470
18.

[Immunosuppression and its use in kidney transplantation].

Paliege A, Bamoulid J, Bachmann F, Staeck O, Halleck F, Khadzhynov D, Brakemeier S, Dürr M, Budde K.

Urologe A. 2015 Oct;54(10):1376-84. doi: 10.1007/s00120-015-3909-x. Review. German.

PMID:
26459580
19.

Identification of T Cell-Mediated Vascular Rejection After Kidney Transplantation by the Combined Measurement of 5 Specific MicroRNAs in Blood.

Matz M, Fabritius K, Lorkowski C, Dürr M, Gaedeke J, Durek P, Grün JR, Goestemeyer A, Bachmann F, Wu K, Rudolph B, Schmidt D, Weber U, Haftmann C, Unterwalder N, Lachmann N, Radbruch A, Neumayer HH, Mashreghi MF, Budde K.

Transplantation. 2016 Apr;100(4):898-907. doi: 10.1097/TP.0000000000000873.

PMID:
26444957
20.

Skin manifestations associated with chronic recurrent multifocal osteomyelitis in a 9-year-old girl.

Bachmann F, Stieler K, Garcia Bartels N, Philipp S, Minden K, Blume-Peytavi U.

J Am Acad Dermatol. 2014 Nov;71(5):e218-9. doi: 10.1016/j.jaad.2014.07.022. Epub 2014 Oct 15. No abstract available.

21.

eIF3a is over-expressed in urinary bladder cancer and influences its phenotype independent of translation initiation.

Spilka R, Ernst C, Bergler H, Rainer J, Flechsig S, Vogetseder A, Lederer E, Benesch M, Brunner A, Geley S, Eger A, Bachmann F, Doppler W, Obrist P, Haybaeck J.

Cell Oncol (Dordr). 2014 Aug;37(4):253-67. doi: 10.1007/s13402-014-0181-9. Epub 2014 Jul 29.

PMID:
25070653
22.

Ligand-based pharmacophore modeling and virtual screening for the discovery of novel 17β-hydroxysteroid dehydrogenase 2 inhibitors.

Vuorinen A, Engeli R, Meyer A, Bachmann F, Griesser UJ, Schuster D, Odermatt A.

J Med Chem. 2014 Jul 24;57(14):5995-6007. doi: 10.1021/jm5004914. Epub 2014 Jul 10.

23.

Non-vitamin K antagonist oral anticoagulants (NOACs): No longer new or novel.

Husted S, de Caterina R, Andreotti F, Arnesen H, Bachmann F, Huber K, Jespersen J, Kristensen SD, Lip GY, Morais J, Rasmussen LH, Siegbahn A, Storey RF, Weitz JI; ESC Working Group on Thrombosis Task Force on Anticoagulants in Heart Disease.

Thromb Haemost. 2014 May 5;111(5):781-2. doi: 10.1160/TH14-03-0228. Epub 2014 Mar 21. No abstract available.

PMID:
24658395
24.

The novel microtubule-destabilizing drug BAL27862 binds to the colchicine site of tubulin with distinct effects on microtubule organization.

Prota AE, Danel F, Bachmann F, Bargsten K, Buey RM, Pohlmann J, Reinelt S, Lane H, Steinmetz MO.

J Mol Biol. 2014 Apr 17;426(8):1848-60. doi: 10.1016/j.jmb.2014.02.005. Epub 2014 Feb 11.

PMID:
24530796
25.

Vitamin K antagonists in heart disease: current status and perspectives (Section III). Position paper of the ESC Working Group on Thrombosis--Task Force on Anticoagulants in Heart Disease.

De Caterina R, Husted S, Wallentin L, Andreotti F, Arnesen H, Bachmann F, Baigent C, Huber K, Jespersen J, Kristensen SD, Lip GY, Morais J, Rasmussen LH, Siegbahn A, Verheugt FW, Weitz JI.

Thromb Haemost. 2013 Dec;110(6):1087-107. doi: 10.1160/TH13-06-0443. Epub 2013 Nov 14. Review.

PMID:
24226379
26.

Recurrent deletion of 3p13 targets multiple tumour suppressor genes and defines a distinct subgroup of aggressive ERG fusion-positive prostate cancers.

Krohn A, Seidel A, Burkhardt L, Bachmann F, Mader M, Grupp K, Eichenauer T, Becker A, Adam M, Graefen M, Huland H, Kurtz S, Steurer S, Tsourlakis MC, Minner S, Michl U, Schlomm T, Sauter G, Simon R, Sirma H.

J Pathol. 2013 Sep;231(1):130-41. doi: 10.1002/path.4223.

PMID:
23794398
27.

Parenteral anticoagulants in heart disease: current status and perspectives (Section II). Position paper of the ESC Working Group on Thrombosis-Task Force on Anticoagulants in Heart Disease.

De Caterina R, Husted S, Wallentin L, Andreotti F, Arnesen H, Bachmann F, Baigent C, Huber K, Jespersen J, Kristensen SD, Lip GY, Morais J, Rasmussen LH, Siegbahn A, Verheugt FW, Weitz JI; European Society of Cardiology Working Group on Thrombosis Task Force on Anticoagulants in Heart Disease.

Thromb Haemost. 2013 May;109(5):769-86. doi: 10.1160/TH12-06-0403. Epub 2013 Mar 28. Review.

PMID:
23636477
28.

CHD1 is a 5q21 tumor suppressor required for ERG rearrangement in prostate cancer.

Burkhardt L, Fuchs S, Krohn A, Masser S, Mader M, Kluth M, Bachmann F, Huland H, Steuber T, Graefen M, Schlomm T, Minner S, Sauter G, Sirma H, Simon R.

Cancer Res. 2013 May 1;73(9):2795-805. doi: 10.1158/0008-5472.CAN-12-1342. Epub 2013 Mar 14.

29.

General mechanisms of coagulation and targets of anticoagulants (Section I). Position Paper of the ESC Working Group on Thrombosis--Task Force on Anticoagulants in Heart Disease.

De Caterina R, Husted S, Wallentin L, Andreotti F, Arnesen H, Bachmann F, Baigent C, Huber K, Jespersen J, Kristensen SD, Lip GY, Morais J, Rasmussen LH, Siegbahn A, Verheugt FW, Weitz JI; European Society of Cardiology Working Group on Thrombosis Task Force on Anticoagulants in Heart Disease.

Thromb Haemost. 2013 Apr;109(4):569-79. doi: 10.1160/TH12-10-0772. Epub 2013 Feb 28. Review.

PMID:
23447024
30.

[Adverse reaction to fillers. Diagnosis and management].

Rzany B, Bachmann F, Nast A.

Hautarzt. 2013 Mar;64(3):163-70. doi: 10.1007/s00105-012-2485-x. German.

PMID:
23443639
31.

[Injectable fillers: adverse reactions and their management].

Rzany B, Bachmann F, Nast A.

Hautarzt. 2013 Feb;64(2):117-25; quiz 126-7. doi: 10.1007/s00105-012-2523-8. Review. German. Erratum in: Hautarzt. 2013 Sep;64(9):698.

PMID:
23407758
32.

Overexpression of eIF3a in Squamous Cell Carcinoma of the Oral Cavity and Its Putative Relation to Chemotherapy Response.

Spilka R, Laimer K, Bachmann F, Spizzo G, Vogetseder A, Wieser M, Müller H, Haybaeck J, Obrist P.

J Oncol. 2012;2012:901956. doi: 10.1155/2012/901956. Epub 2012 Apr 23.

33.

A structured multi-stakeholder learning process for Sustainable Land Management.

Schwilch G, Bachmann F, Valente S, Coelho C, Moreira J, Laouina A, Chaker M, Aderghal M, Santos P, Reed MS.

J Environ Manage. 2012 Sep 30;107:52-63. doi: 10.1016/j.jenvman.2012.04.023. Epub 2012 May 10.

PMID:
22579832
34.

New oral anticoagulants in atrial fibrillation and acute coronary syndromes: ESC Working Group on Thrombosis-Task Force on Anticoagulants in Heart Disease position paper.

De Caterina R, Husted S, Wallentin L, Andreotti F, Arnesen H, Bachmann F, Baigent C, Huber K, Jespersen J, Kristensen SD, Lip GY, Morais J, Rasmussen LH, Siegbahn A, Verheugt FW, Weitz JI; Coordinating Committee.

J Am Coll Cardiol. 2012 Apr 17;59(16):1413-25. doi: 10.1016/j.jacc.2012.02.008. Review.

35.

Psychopathology and offense types in detained male juveniles.

Plattner B, Giger J, Bachmann F, Brühwiler K, Steiner H, Steinhausen HC, Bessler C, Aebi M.

Psychiatry Res. 2012 Jul 30;198(2):285-90. doi: 10.1016/j.psychres.2012.02.006. Epub 2012 Mar 23.

PMID:
22445705
36.

Efficacy of systemic therapies for moderate-to-severe psoriasis: a systematic review and meta-analysis of long-term treatment.

Lucka TC, Pathirana D, Sammain A, Bachmann F, Rosumeck S, Erdmann R, Schmitt J, Orawa H, Rzany B, Nast A.

J Eur Acad Dermatol Venereol. 2012 Nov;26(11):1331-44. doi: 10.1111/j.1468-3083.2012.04492.x. Epub 2012 Mar 9. Review. Erratum in: J Eur Acad Dermatol Venereol. 2012 Jul;26(7):930.

PMID:
22404617
37.

Grain detection from 2d and 3d EBSD data--specification of the MTEX algorithm.

Bachmann F, Hielscher R, Schaeben H.

Ultramicroscopy. 2011 Dec;111(12):1720-33. doi: 10.1016/j.ultramic.2011.08.002. Epub 2011 Sep 7.

PMID:
22094374
38.

Efficacy and durability of two hyaluronic acid-based fillers in the correction of nasolabial folds: results of a prospective, randomized, double-blind, actively controlled clinical pilot study.

Nast A, Reytan N, Hartmann V, Pathirana D, Bachmann F, Erdmann R, Rzany B.

Dermatol Surg. 2011 Jun;37(6):768-75. doi: 10.1111/j.1524-4725.2011.01993..x.

PMID:
21605236
39.

Consecutively injected fillers in the same region do not pose an increased risk for adverse reactions.

Bachmann F, Erdmann R, Hartmann V, Rzany B.

J Eur Acad Dermatol Venereol. 2011 Jun;25(6):737-8. doi: 10.1111/j.1468-3083.2011.04052.x. Epub 2011 Apr 26. No abstract available.

PMID:
21518022
40.

Adverse reactions caused by consecutive injections of different fillers in the same facial region: risk assessment based on the results from the Injectable Filler Safety study.

Bachmann F, Erdmann R, Hartmann V, Becker-Wegerich P, Wiest L, Rzany B.

J Eur Acad Dermatol Venereol. 2011 Aug;25(8):902-12. doi: 10.1111/j.1468-3083.2010.03878.x. Epub 2010 Nov 4.

PMID:
21054567
41.

The current state of treatment of adverse reactions to injectable fillers.

Sperling B, Bachmann F, Hartmann V, Erdmann R, Wiest L, Rzany B.

Dermatol Surg. 2010 Nov;36 Suppl 3:1895-904. doi: 10.1111/j.1524-4725.2010.01782.x.

PMID:
20969667
42.

Overexpression of p150, a part of the large subunit of the eukaryotic translation initiation factor 3, in colon cancer.

Haybaeck J, O'Connor T, Spilka R, Spizzo G, Ensinger Ch, Mikuz G, Brunhuber T, Vogetseder A, Theurl I, Salvenmoser W, Draxl H, Bänziger R, Bachmann F, Schäfer G, Burger M, Obrist P.

Anticancer Res. 2010 Apr;30(4):1047-55.

PMID:
20530408
43.

Safety and efficacy of the tumor necrosis factor antagonists.

Bachmann F, Nast A, Sterry W, Philipp S.

Semin Cutan Med Surg. 2010 Mar;29(1):35-47. doi: 10.1016/j.sder.2010.02.002. Review.

PMID:
20430306
44.

[Esthetic dermatology for students: good acceptability of a new voluntary seminar].

Krezdorn N, Hartmann V, Bachmann F, Nast A, Rzany B.

J Dtsch Dermatol Ges. 2010 Apr;8(4):281-3. doi: 10.1111/j.1610-0387.2010.07407.x. German. No abstract available.

PMID:
20409088
45.

Orthogonal, three-component, alkanethiol-based surface-chemical gradients on gold.

Beurer E, Venkataraman NV, Rossi A, Bachmann F, Engeli R, Spencer ND.

Langmuir. 2010 Jun 1;26(11):8392-9. doi: 10.1021/la904830h.

PMID:
20166727
46.

Hyaluronidase in the correction of hyaluronic acid-based fillers: a review and a recommendation for use.

Rzany B, Becker-Wegerich P, Bachmann F, Erdmann R, Wollina U.

J Cosmet Dermatol. 2009 Dec;8(4):317-23. doi: 10.1111/j.1473-2165.2009.00462.x. Review.

PMID:
19958438
47.

The spectrum of adverse reactions after treatment with injectable fillers in the glabellar region: results from the Injectable Filler Safety Study.

Bachmann F, Erdmann R, Hartmann V, Wiest L, Rzany B.

Dermatol Surg. 2009 Oct;35 Suppl 2:1629-34. doi: 10.1111/j.1524-4725.2009.01341.x.

PMID:
19807757
48.

Hand augmentation with stabilized hyaluronic acid (Macrolane VRF20 and Restylane Vital, Restylane Vital Light).

Hartmann V, Bachmann F, Plaschke M, Gottermeier T, Nast A, Rzany B.

J Dtsch Dermatol Ges. 2010 Jan;8(1):41-4. doi: 10.1111/j.1610-0387.2009.07271.x. Epub 2009 Oct 9. English, German.

PMID:
19817949
49.

Risk of severe adverse reactions to an injectable filler based on a fixed combination of hydroxyethylmethacrylate and ethylmethacrylate with hyaluronic acid.

Rossner M, Rossner F, Bachmann F, Wiest L, Rzany B.

Dermatol Surg. 2009 Feb;35 Suppl 1:367-74. doi: 10.1111/j.1524-4725.2008.01062.x.

PMID:
19207327
50.

The discovery of factor X: a personal reminiscence.

Bachmann F.

Thromb Haemost. 2007 Jul;98(1):16-9. No abstract available.

PMID:
17597984

Supplemental Content

Loading ...
Support Center